Larvol Delta - CicloMed-Announces-Initiation-of-Phase-1B-Trial-of-Fosciclopirox-in-Newly-Diagnosed-and-Recurrent-Urothelial-Cancer-Patients

fosciclopirox (CPX-POM) - BioNOVUS, University of Kansas Medical Center

https://www.globenewswire.com/news-release/2021/06/29/2254634/0/en/CicloMed-Announces-Initiation-of-Phase-1B-Trial-of-Fosciclopirox-in-Newly-Diagnosed-and-Recurrent-Urothelial-Cancer-Patients.html

Jun 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next